New sigma and 5-HT1A receptor ligands: omega-(tetralin-1-yl)-n-alkylamine derivatives

被引:40
作者
Berardi, F [1 ]
Colabufo, NA [1 ]
Giudice, G [1 ]
Perrone, R [1 ]
Tortorella, V [1 ]
Govoni, S [1 ]
Lucchi, L [1 ]
机构
[1] UNIV MILAN,IST SCI FARMACOL,I-20133 MILAN,ITALY
关键词
D O I
10.1021/jm950409c
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Two series of compounds that are structurally related to benzomorphans, derived by structural modification of arylpiperazines with high 5-HT1A affinity and moderate a affinity, were prepared in order to increase a affinity and selectivity. All new compounds are N-substituted-omega-(1,2,3,4-tetrahydronaphthalen-1-yl)- or -omega-(1,2-dihydronaphthalen-4-yl)-n-alkylamines with, in some cases, a methoxy group on the tetralin moiety. They were tested in radioligand binding assays on sigma ([H-3]DTG and [H-3]-(+)-pentazocine), D-2 dopaminergic, 5-HT1A and 5-HT2 serotonergic, and PCP (phencyclidine) receptors. A first set of compounds bearing a 4-(1-substituted)piperazine moiety as terminal fragment on the alkyl chain showed moderate to high sigma affinity (K-i = 5.3-139 nM), the most active and selective being 1-cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)-n-proyl]piperazine (14), with probable pronounced alpha(2) affinity (K-i = 5.3 nM on [H-3]DTG and K-i = 71 nM on [H-3]-(+)-pentazocine). Moreover, compound 13, a 1-benzylpiperazine analogue of 14, preserved a dual high 5-HT1A and sigma affinity (K-i = 3.6 nM on [H-3]-5-HT and K-i = 7.0 nM on [H-3]DTG). The second set of compounds includes some N-phenylalkyl derivatives of 3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)-n-propylamine that can be considered. to be open-chain derivatives of 4-substituted-1-arylpiperazines. Among these compounds that had a lower activity toward sigma binding sites, a high 5-HT1A affinity was found for the N-(3-phenylpropyl) derivative 21 (K-i = 4.4 nM) which demonstrated very good selectivity.
引用
收藏
页码:176 / 182
页数:7
相关论文
共 33 条
[1]  
ABLORDEPPEY SY, 1993, MED CHEM RES, V3, P131
[2]  
ABLORDEPPEY SY, 1991, MED CHEM RES, V1, P425
[3]  
BOOTH RG, 1993, MOL PHARMACOL, V44, P1232
[4]  
BOOTH RG, 1994, MED CHEM RES, V4, P225
[5]   2 BINDING-SITES FOR H-3-SPIROPERIDOL ON RAT STRIATAL MEMBRANES [J].
BRILEY, M ;
LANGER, SZ .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1978, 50 (03) :283-284
[6]   [H-3] (+)-PENTAZOCINE BINDING TO RAT-BRAIN SIGMA(1) RECEPTORS [J].
CAGNOTTO, A ;
BASTONE, A ;
MENNINI, T .
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1994, 266 (02) :131-138
[7]   ENANTIOMERIC N-SUBSTITUTED N-NORMETAZOCINES - A COMPARATIVE-STUDY OF AFFINITIES AT SIGMA, PCP, AND MU OPIOID RECEPTORS [J].
CARROLL, FI ;
ABRAHAM, P ;
PARHAM, K ;
BAI, X ;
ZHANG, X ;
BRINE, GA ;
MASCARELLA, SW ;
MARTIN, BR ;
MAY, EL ;
SAUSS, C ;
DIPAOLO, L ;
WALLACE, P ;
WALKER, JM ;
BOWEN, WD .
JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (15) :2812-2818
[8]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[9]   CHARACTERIZATION OF THE BINDING OF [H-3] (+)-PENTAZOCINE TO SIGMA-RECOGNITION SITES IN GUINEA-PIG BRAIN [J].
DEHAVENHUDKINS, DL ;
FLEISSNER, LC ;
FORDRICE, FY .
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1992, 227 (04) :371-378
[10]   THE SIGMA-RECEPTOR - A NOVEL SITE IMPLICATED IN PSYCHOSIS AND ANTIPSYCHOTIC DRUG EFFICACY [J].
DEUTSCH, SI ;
WEIZMAN, A ;
GOLDMAN, ME ;
MORIHISA, JM .
CLINICAL NEUROPHARMACOLOGY, 1988, 11 (02) :105-119